HOUSTON, Texas — August 27, 2025 — Leads & Copy — FibroBiologics, Inc. (Nasdaq: FBLG), a clinical-stage biotechnology company, announced that Founder and CEO Pete O’Heeron will present at the H.C. Wainwright 27th Annual Global Investment Conference from Sept. 8-10 at the Lotte New York Palace Hotel in New York City.
FibroBiologics will give a company presentation at 12:00 p.m. ET on Sept. 10 and be available for one-on-one investor meetings throughout the event.
FibroBiologics is based in Houston and is developing treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 275+ U.S. and international patents/patents pending across clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer.
General inquiries can be directed to info@fibrobiologics.com. Investor relations can be directed to Nic Johnson at Russo Partners at (212) 845-4242 or fibrobiologicsIR@russopr.com. Media contact is Liz Phillips at Russo Partners at (347) 956-7697 or Elizabeth.phillips@russopartnersllc.com.
Source: FibroBiologics
